{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:14:28Z","timestamp":1778753668757,"version":"3.51.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06959-5","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T08:39:38Z","timestamp":1776674378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual oral iron chelation with deferasirox and deferiprone in transfusion-dependent \u03b2-thalassemia: a narrative review of efficacy, safety, and practical application"],"prefix":"10.1007","volume":"105","author":[{"given":"Vinson","family":"James","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina Ifeoma","family":"Emeghebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"9","key":"6959_CR1","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","volume":"107","author":"C Borgna-Pignatti","year":"2006","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P et al (2006) Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood 107(9):3733\u20133737","journal-title":"Blood"},{"issue":"9","key":"6959_CR2","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1182\/blood-2006-02-002394","volume":"107","author":"EJ Neufeld","year":"2006","unstructured":"Neufeld EJ (2006) Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 107(9):3436\u20133441","journal-title":"Blood"},{"issue":"3","key":"6959_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s13312-016-0821-4","volume":"53","author":"S Gomber","year":"2016","unstructured":"Gomber S, Jain P, Sharma S, Narang M (2016) Comparative efficacy and safety of oral iron chelators and their novel combination in children with thalassemia. Indian Pediatr 53(3):207\u2013210","journal-title":"Indian Pediatr"},{"issue":"3","key":"6959_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1097\/MPH.0000000000000780","volume":"39","author":"N Parakh","year":"2017","unstructured":"Parakh N, Chandra J et al (2017) Efficacy and safety of combined oral chelation with deferiprone and deferasirox in children with \u03b2-thalassemia major: an experience from North India. J Pediatr Hematol Oncol 39(3):209\u2013213","journal-title":"J Pediatr Hematol Oncol"},{"issue":"4","key":"6959_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s12098-020-03442-5","volume":"88","author":"RR DivakarJose","year":"2021","unstructured":"DivakarJose RR, Delhikumar CG, Ram Kumar G (2021) Efficacy and safety of combined oral chelation with deferiprone and deferasirox on iron overload in transfusion-dependent children with thalassemia: a prospective observational study. Indian J Pediatr 88(4):330\u2013335","journal-title":"Indian J Pediatr"},{"issue":"1","key":"6959_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12288-024-01804-z","volume":"41","author":"AS Chadha","year":"2024","unstructured":"Chadha AS et al (2024) Dual oral iron chelation (DOIC) in children with transfusion-dependent beta thalassemia: real-world efficacy data. Indian J Hematol Blood Transfus 41(1):167\u2013170","journal-title":"Indian J Hematol Blood Transfus"},{"key":"6959_CR7","doi-asserted-by":"publisher","unstructured":"James V, Prakash A (2025) Efficacy of combination chelation with deferasirox and deferiprone in children with beta-thalassemia major: an audit from a unit in the developing world. Clin Exp Med 25(1):299. https:\/\/doi.org\/10.1007\/s10238-025-01687-y. PMID: 40844717; PMCID: PMC12373522","DOI":"10.1007\/s10238-025-01687-y"},{"issue":"1","key":"6959_CR8","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1097\/MPH.0000000000001269","volume":"41","author":"J Hammond","year":"2019","unstructured":"Hammond J, Thompson AA et al (2019) Combination oral chelation in adult patients with transfusion-dependent thalassemia and high iron burden. J Pediatr Hematol Oncol 41(1):e47\u2013e50","journal-title":"J Pediatr Hematol Oncol"},{"key":"6959_CR9","doi-asserted-by":"crossref","unstructured":"Borgna-Pignatti C Survival and complications in thalassemia., Ann N Y Acad Sci, Rachmilewitz EA, Giardina PJ et al (2005) How I treat thalassemia. Blood 2011;118(13):3479\u20133488","DOI":"10.1182\/blood-2010-08-300335"},{"issue":"13","key":"6959_CR10","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1182\/blood-2010-08-300335","volume":"118","author":"A Eliezer","year":"2011","unstructured":"Eliezer A, Rachmilewitz, Patricia J (2011) Giardina; How I treat thalassemia. Blood 118(13):3479\u20133488","journal-title":"Blood"},{"issue":"9","key":"6959_CR11","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","volume":"107","author":"MD Cappellini","year":"2006","unstructured":"Cappellini MD, Cohen A, Piga A et al (2006) A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with \u03b2-thalassemia. Blood 107(9):3455\u20133462","journal-title":"Blood"},{"issue":"1","key":"6959_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","volume":"102","author":"AV Hoffbrand","year":"2003","unstructured":"Hoffbrand AV, Cohen A, Hershko C (2003) Role of deferiprone in chelation therapy for transfusional iron overload. Blood 102(1):17\u201324","journal-title":"Blood"},{"issue":"7","key":"6959_CR13","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.3390\/jcm11072010","volume":"11","author":"R Origa","year":"2022","unstructured":"Origa R, Cinus M et al (2022) Safety and efficacy of the new combination iron chelation regimens in patients with transfusion-dependent thalassemia and severe iron overload. J Clin Med 11(7):2010","journal-title":"J Clin Med"},{"issue":"6","key":"6959_CR14","first-page":"461","volume":"25","author":"A Maggio","year":"2011","unstructured":"Maggio A et al (2011) Combination iron chelation therapy: a systematic review. Blood Rev 25(6):461\u2013473","journal-title":"Blood Rev"},{"issue":"6","key":"6959_CR15","doi-asserted-by":"publisher","first-page":"480","DOI":"10.2471\/blt.06.036673","volume":"86","author":"B Modell","year":"2008","unstructured":"Modell B, Darlison M (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 86(6):480\u2013487. https:\/\/doi.org\/10.2471\/blt.06.036673. PMID: 18568278; PMCID: PMC2647473","journal-title":"Bull World Health Organ"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06959-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06959-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06959-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:22:28Z","timestamp":1778750548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06959-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":15,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["6959"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06959-5","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is a narrative review and does not involve human participants or animal research. This study has been approved by the Academic Development Committee of Good Samaritan University Hospital, West Islip, NY 11795.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"256"}}